The Effect of Platelet-Rich Plasma on Allograft Transplantation after Curettage in Benign Bone Tumor.
10.5292/jkbjts.2010.16.1.8
- Author:
Jae Do KIM
;
Ji Youn KIM
;
Su Jin JANG
;
So Hak CHUNG
;
Gu Hee JUNG
- Publication Type:Original Article
- Keywords:
benign bone tumor;
allograft transplantation;
platelet-rich plasma (PRP)
- MeSH:
Acceleration;
Anti-Bacterial Agents;
Bone Cysts;
Bone Resorption;
Chondroma;
Curettage;
Follow-Up Studies;
Fractures, Spontaneous;
Giant Cell Tumors;
Humans;
Platelet-Rich Plasma;
Recurrence;
Transplantation, Homologous;
Transplants
- From:The Journal of the Korean Bone and Joint Tumor Society
2010;16(1):8-13
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: This study was performed to evaluate the efficiency of Platelet-rich plasma (PRP) for acceleration of bone healing process on allograft transplantation after curettage in benign bone tumor. MATERIALS AND METHODS: From December 2007 to February 2009, twenty-one patients who had benign bone tumor and underwent allograft transplantation after curettage were evaluated. Mean follow-up period was 14.6 months (range, 12-26 months). We compared with 13 cases of PRP group and 8 cases of non-PRP group in terms of size of lesion, bone resorption, amount of applied PRP and complications. The mean age at surgery was 23.6 years (range, 4-73 years). The most common diagnosis was simple bone cyst (7) followed by enchondroma (4), giant cell tumor (3), undifferentiated benign bone tumor (3) and so on. RESULTS: The mean size of lesion was 33.5 cm3 (range, 2.3-181.9 cm3) (29.4 cm3 in PRP group and 40.2 cm3 in non-PRP group). The mean volume of injected PRP was 7.4 cc (range, 3-12 cc). Bone union started at 3.0 months (range, 1.5-5.8 months) in PRP group and 5.3 months (range, 4-8 months) in non-PRP group. Three cases for each group were excluded due to recurrence and pathologic fracture. One patient had febrile episode 3 weeks later after surgery which subsided with antibiotics. CONCLUSION: The PRP could accelerate bone union in allograft transplantation after curettage of benign bone tumor. Furthermore, we expect that PRP can accelerate bone union in fracture or non-union.
